OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
8
Results
Show all
Save search
Copy query
Show results for
Unknown
(8)
Publication Date
Release Date
2024
(2)
2022
(2)
2025
(1)
2023
(1)
2021
(1)
2019
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
How to attract and retain health workers in rural areas of a fragile state: Findings from a labour market survey in Guinea.
Not available
S-EPMC8675729
|
biostudies-literature
Cite
Non-communicable disease policy implementation in Libya: A mixed methods assessment.
Not available
S-EPMC10021530
|
biostudies-literature
Cite
IL-33 Signaling Alters Regulatory T Cell Diversity in Support of Tumor Development.
Not available
S-EPMC6990979
|
biostudies-literature
Cite
Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non-Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial.
Not available
S-EPMC10082285
|
biostudies-literature
Cite
Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial.
Not available
S-EPMC9359973
|
biostudies-literature
Cite
Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients.
Not available
S-EPMC11227881
|
biostudies-literature
Cite
Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma.
Not available
S-EPMC12080919
|
biostudies-literature
Cite
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.
Not available
S-EPMC11560846
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets